References
Weitz J, Koch M, Debus J et al (2005) Colorectal cancer. Lancet 365:153–165
Morito T, Fujihara M, Asaoku H et al (2009) Serum soluble interleukin-2 receptor level and immunophenotype are prognostic factors for patients with diffuse large B-cell lymphoma. Cancer Sci 100:1255–1260
Tartour E, Mosseri V, Jouffroy T et al (2001) Serum soluble interleukin-2 receptor concentrations as an independent prognostic marker in head and neck cancer. Lancet 357:1263–1267
Alberts SR, Sargent DJ, Nair S et al (2012) Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer. JAMA 307:1383–1393
Acknowledgments
This study was supported by the National Natural Science Foundation of China (no. 81072743) and Province Key Lab grant (no. LS2010102) awarded by the Department of Education of Liaoning Province, China.
Conflict of interest
No potential conflict of interest relevant to this article was reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, X., Zhang, Y., Zhang, J. et al. Impact of preoperative serum interleukin-2 receptor alpha levels on survival and its correlation with clinicopathological parameters in colorectal cancer. Int J Colorectal Dis 28, 1591–1593 (2013). https://doi.org/10.1007/s00384-012-1638-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-012-1638-9